IPO Details
Bidding Dates
06 Jan 25 - 08 Jan 25
Price Range ₹
133 - 140
Total Equity
₹ 291.61Cr
Lot Size
107
Exchange Status
NSE,BSE
IPO Doc
Subscription Rate
Non-Institutional Investor
64.99×
Qualified Institutional Buyers
331.60×
Employees
0.00×
Retail Investors
64.99×
Total subscription Rate
183.18×
IPO Timeline
Offer start
06 Jan 2025
Offer end
08 Jan 2025
Allotment
09 Jan 2025
Refund initiation
10 Jan 2025
Demat transfer
10 Jan 2025
Listing
13 Jan 2025
Offer start
06 Jan 2025
Offer end
08 Jan 2025
Allotment
09 Jan 2025
Refund initiation
10 Jan 2025
Demat transfer
10 Jan 2025
Listing
13 Jan 2025
About Company
Standard Glass Lining Technology Limited, established in September 2012, is a leading manufacturer of engineering equipment for the pharmaceutical and chemical industries in India. The company has the capability to handle the complete production process internally, offering turnkey solutions that encompass design, engineering, manufacturing, assembly, installation, and the creation of standard operating procedures for its clients in these sectors. Its diverse product portfolio includes Reaction Systems, Storage, Separation and Drying Systems, and Plant Engineering and Services. The company specializes in manufacturing high-quality engineering equipment using materials such as glass-lined steel, stainless steel, and nickel alloy. Notable customers include prominent names like Apitoria Pharma, Aurobindo Pharma, CCL Food and Beverages, Cohance Lifesciences, Cadila Pharmaceuticals, Deccan Fine Chemicals, Laurus Labs, Granules India, Macleods Pharmaceuticals, MSN Laboratories, Natco Pharma, and several others from the pharmaceutical and chemical industries. The company operates eight manufacturing facilities located in Hyderabad, Telangana, and has sales offices in Vadodara, Ankleshwar, Mumbai, and Vishakhapatnam. With a pan-India sales network covering regions like Jhagadia, Chennai, New Delhi, Bengaluru, and Vijayawada, it ensures wide-reaching distribution. As of September 30, 2024, Standard Glass Lining Technology employs 460 full-time staff and 731 contract workers. Its competitive advantages include its specialization in engineering equipment for the pharmaceutical and chemical sectors, an innovative product range tailored to the needs of the industry, strategically located manufacturing units equipped with advanced technology, strong relationships with a prestigious client base, and a proven record of steady, profitable growth.
Year Founded
06-09-2012
Promotor Details
Sambasiva Rao Gollapudi
Promoter Holdings Details
| Particular | Pre-IPO | Post-IPO |
|---|---|---|
| Percentage | 75.69 | 60.41 |
| Share Capital | 137486350 | 120506350 |
Offer to Public
2,08,29,567.00 Cr
Project Details
- Funding of capital expenditure requirements of our Company towards purchase of machinery and equipme - 100cr
- Repayment or prepayment, in full or in part, of all or a portion of certain outstanding borrowings - 1300cr
- Funding inorganic growth through strategic investments and/or acquisitions - 200cr
- Investment in our wholly owned Material Subsidiary, S2 Engineering Industry Private Limited - 300cr
Objectives
- Funding of capital expenditure requirements of our Company towards purchase of machinery andequipment
- Repayment or prepayment, in full or in part, of all or a portion of certain outstanding borrowings availed by our Company and investment in our wholly owned Material Subsidiary, S2 Engineering Industry Private Limited, for repayment or prepayment, in full or in part, of all or a portion of certain outstanding borrowings availed by S2 Engineering Industry Private Limited, from banks and financial institutions
- Investment in our wholly owned Material Subsidiary, S2 Engineering Industry Private Limited, for funding its capital expenditure requirements towards purchase of machinery and equipment
- Funding inorganic growth through strategic investments and/or acquisitions
- andGeneral corporate purposes.
Highlights
- Recognized as one of the top five specialized engineering equipment manufacturers for India's pharmaceutical and chemical industries.
- Leading producer of equipment made from glass-lined, stainless steel, and nickel alloy materials in India.
- Provides custom solutions for the pharmaceutical, chemical, food, and beverage sectors.
- Delivered over 11,000 products in the past decade, catering to a wide range of industry requirements.
- Manufactures stainless steel glass-lined reactors in-house, with capacities of up to 10KL, and partners with HHV Pumps and GL Hakko to enhance product offerings and market presence. Equipped with advanced CNC plasma, laser cutting, and welding technologies.
Challenges
- The company has guaranteed subsidiary loans, with potential defaults leading to costs that could affect profitability.
- There is a significant reliance on the pharmaceutical and chemical sectors, which exposes the company to sector-specific risks.
- The company faces risks from under-utilization of its manufacturing capacity.
- Delays or defaults in customer payments pose a financial risk to the company.
- The company is vulnerable to fluctuations in raw material costs and has limited ability to pass on these increases to customers. Additionally, its dependence on facilities in Telangana exposes it to risks from natural disasters and political changes.
Financials
| Years | Total Assets | Share Capital | Profit After Tax | Consolidated Net Profit | Adjusted EPS |
|---|---|---|---|---|---|
| 2023 | 3,624.98 | 157.85 | 251.45 | 251.45 | 1.6435 |
| 2024 | 6,845.28 | 181.63 | 600.11 | 583.84 | 3.2144 |
| 2022 | 3,052.56 | 153.00 | 251.45 | 251.45 | 1.6435 |
